REFERENCES
- Anderson B. M., Jackson F., Moxley M. A., Longmore W. J.. 1992. Effects on experimental acute lung injury 24 h after exogenous surfactant instillation. Exp. Lung Res.. 18: 191–204. [PUBMED], [INFOTRIEVE], [CSA]
- Babior B. M., Kipnes R. S., Curnutte J. T.. 1973. Biological defense mechanisms. The production by leucocytes of superoxide, a potential bactericidal agent. J. Clin. Invest.. 52: 741–744. [PUBMED], [INFOTRIEVE], [CSA]
- Baker G., Duck-Chong C., Cleland K., Berend N.. 1986. The surfactant system as an intrinsic monitor of acute interstitial lung disease. Chest. 89: 126s–127s. [CSA]
- Bastacky J., Goerke J., Lee C. Y., Yager D., Kenaga L., Koushafar H., Hayes T. L., Chen Y., Clements J. A.. 1993. Alveolar lining liquid layer is thin and continuous: Low temperature scanning electron microscopy of normal rat lung. Am. Rev. Respir. Dis.. 147:A148, [CSA]
- Bergers W. W. A., Beyersbergen A. G., Hammer A. H., Bruijnzeel P.. 1996. Breathing pattern of awake rats exposed to acroleine and perfluoroisobutylene determined with an integrated system of nose-only exposure and online analyzed multiple monitoring of breathing. Inhal. Toxicol.. 8: 81–93. [CSA]
- Brogden K. A.. 1991. Changes in pulmonary surfactant during bacterial pneumonia. Antonie van Leeuwenhoek. 59: 215–223. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Brown R. F., Rice P.. 1991. Electron microscopy of rat lung following a single acute exposure to perfluoroisobutene (PFIB). A sequential study of the first 24 hours following exposure. Int. J. Exp. Pathol.. 72: (4):437–450. [INFOTRIEVE], [CSA]
- Brouwers F. H. M., Vernooij A. A. M., Tielens A. G. M., Van, Golde L. M. G.. 1999. Rapid separation and identification of phosphatidylethanolaminespecies. J. Lipid Res.. 40: 164–169. [PUBMED], [INFOTRIEVE], [CSA]
- Calvet J., Jarreau P., Levame M., D'orthe M., Harf A., Macquin-Mavier I.. 1994. Acute and chronic respiratory effects of sulfur mustard intoxication in guinea pigs. J. Appl. Physiol.. 76: (2):681–688. [INFOTRIEVE], [CSA]
- Danishevskii S. L., Kochanov M. M.. 1961. Toxicity of some fluoroorganic compounds. Gig. Tr. Prof. Zabol.. 5: 3–8. [CSA]
- Eijking E. P., Gommers D., So K. L., Vergeer M., Lachmann B.. 1993. Surfactant treatment of respiratory failure induced by hydrochloric acid aspiration in rats. Anesthesiology. 78: 1145–1151. [PUBMED], [INFOTRIEVE], [CSA]
- Gross N. J.. 1991. Surfactant subtypes in experimental lung damage: Radiation pneumonitis. Am. J. Physiol. 260: L302–L310. [PUBMED], [INFOTRIEVE], [CSA]
- Haagsman H. P.. 1992. Toxicological aspects of the surfactant system. Pulmonary surfactant: From molecular biology to clinical practice, B., Robertson, L. M.G., van, Golde, J. J., Batenburg, Amsterdam, Elsevier Science
- Haagsman H. P., Van, Golde L. M. G.. 1991. Synthesis and assembly of lung surfactant. Annu. Rev. Physiol.. 53: 441–464. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hamm H., Fabel H., Bartsch W.. 1992. The surfactant system of the adult lung: Physiology and clinical perspectives. Clin. Invest.. 70: 637–657. [CSA]
- Honda Y., Tsunematsu K., Suzuki A., Akino T.. 1988. Changes in phospholipids in bronchoalveolar lavage fluid of patients with interstitial lung diseases. Lung. 166: 293–301. [PUBMED], [INFOTRIEVE], [CSA]
- Honda Y., Tsunematsu K., Suzuki A., Akino T.. 1989. Alterations of acidic phospholipids in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Clin. Chim. Acta. 181: 11–18. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jugg B., Jenner J., Rice P.. 1999. The effect of perfluoroisobutene and phosgene on rat lavage fluid surfactant phospholipids. Hum. Toxicol.. 18: 659–668. [CROSSREF], [CSA]
- Lailey A. P., Hill L., Lawston D., Upshall D. G.. 1991. Protection by cysteine esters against chemically induced pulmonary oedema. Biochem. Pharmacol.. 42:S47–S54. [CSA]
- Lehnert B. E., Archuleta D., Behr M. J., Stavert D. M.. 1993. Lung injury after acute inhalation of perfluoroisobutylene: Exposure concentration-response relationships. Inhal. Toxicol.. 5: 1–32. [CSA]
- Lehnert B. E., Archuleta D., Gurley L. R., Session W., Behr M. J., Lehnert N. M., Stavert D. M.. 1995. Exercise potentiation of lung injury following inhalation of a pneumoedematogenic gas: Perfluoroisobutene. Exp. Lung Res.. 21: (2):331–350. [INFOTRIEVE], [CSA]
- Lewis J. F., Jobe A. H.. 1993. Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis.. 147: 218–233. [PUBMED], [INFOTRIEVE], [CSA]
- Maidment M. P., Upshall D. G.. 1992. Retention of inhaled perfluoroisobutene in the rat. J. Appl. Toxicol.. 12: (6):393–400. [INFOTRIEVE], [CSA]
- Moylan J. A., Alexander L. G.. 1978. Diagnosis and treatment of inhalation injury. World J. Surg.. 2: 185–191. [PUBMED], [INFOTRIEVE], [CSA]
- Nieman G. F., Clark W. R.. 1994. Effects of wood and cotton smoke on the surface properties of pulmonary surfactant. Respir. Physiol.. 97: 1–12. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Patocka J., Bajgar J.. 1998. Toxicology of perfluoroiso- butene. Applied Science and Analysis. The ASA Newsletter, http://www.asanltr.com/ASANews-98/pfib.htm, [CSA]
- Putz G., Goerke J., Schürch S., Clements J. A.. 1994a. Evaluation of pressure-driven captive bubble surfactometer. J. Appl. Physiol.. 76: 1417–1424. [PUBMED], [INFOTRIEVE], [CSA]
- Putz G., Goerke J., Taeusch H. W., Clements J. A.. 1994b. Comparison of captive and pulsating bubble surfactometers with use of lung surfactants. J. Appl. Physiol.. 76: 1425–1431. [PUBMED], [INFOTRIEVE], [CSA]
- Putz G., Walch M., Van, Eijk M., Haagsman H. P.. 1998. A spreading technique for forming in a captive bubble. Biophys. J.. 75: 2229–2239. [PUBMED], [INFOTRIEVE], [CSA]
- Putz G., Walch M., Van, Eijk M., Haagsman H. P.. 1999. Hydrophobic lung surfactant proteins B and C remain associated with surface film during dynamic cyclic area changes. BBA. 1: (1453):126–134. [CSA]
- Robinson N. B., Hudson L. D., Riem M., Miller E.. 1982. Steroid therapy following isolated smoke inhalation injury. J. Trauma. 22: 816–879. [CSA]
- Salmona M.. 1992. A novel pharmacological approach for paraquat poisoning in rat and U549 cell line using Ambroxol, a lung surfactant synthesis inducer. Food Chem. Toxicol.. 30: 789–794. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sciuto A. M., Strickland P. T., Kennedy T. P., Gunther G. H.. 1995. Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits. Am. J. Respir. Crit. Care Med.. 151: 768–772. [PUBMED], [INFOTRIEVE], [CSA]
- Seeger W., Gunther A., Walmrath H. D., Grimminger F., Lasch H. G.. 1993. Alveolar surfactant and adult respiratory distress syndrome; pathogenetic role and therapeutic prospects. Clin. Invest.. 71: 177–190. [CSA]
- Thomassen M. J., Meeker D. P., Antal J. M., Connors M. J., Wiedemann H. P.. 1992. Synthetic surfactant (Exosurf) inhibits endotoxine-stimulated cytokine secretion by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol.. 7: 257–260. [PUBMED], [INFOTRIEVE], [CSA]
- van, Helden H. P. M., Kuijpers W. C., Steenvoorden D., Go C., Bruijnzeel P. L. B., Van, Eijk M., Haagsman H. P.. 1997. Intratracheal aerosolization of endotoxin (LPS) in the rat: A comprehensive animal model to study adult (acute) respiratory distress syndrome (ARDS). Exp. Lung Res.. 23: 297–315. [PUBMED], [INFOTRIEVE], [CSA]
- van, Helden H. P. M., Kuijpers W. C., Langenwerf P. E. J., Langen R. C. J., Haagsman H. P., Bruijnzeel P.. 1998. Efficacy of Curosurf in a rat model of acute respiratory distress syndrome. Eur. Respir. J.. 12: 533–539. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- van, Helden H. P. M., Kuijpers W. C., Diemel R.. 2004. Asthmalike symptoms following intratracheal exposure of guinea pigs to sulfur mustard aerosol: Therapeutic efficacy of exogenous lung surfactant Curosurf and Salbutamol. Inhal. Toxicol., [CSA]
- Wright J. R.. 1990. Clearance and recycling of pulmonary surfactant. Am. J. Physiol. 259: L1–L12. [PUBMED], [INFOTRIEVE], [CSA]